A federal court judge said the Health and Human Services Department had overreached its regulatory authority in trying to force drugmakers to disclose their prices.
from NYT > Business https://ift.tt/2NHsxg0
Subscribe to:
Post Comments (Atom)
'Clients bring back entire wardrobes': Tailors say Ozempic is reshaping Wall Street
Michael Andrews is the co-founder and CEO of Michael Andrews Bespoke. Christian Rodriguez for BI In his two decades as a Wall Street tai...
-
Caroline Purser/Getty Images The S&P 500 has shed 4% since the beginning of the year as Big Tech stocks decline. However, previou...
-
AP Photo The Magnificent Seven stocks' dominance may soon fade, warns Glenmede Investment Management. Current market concentratio...
-
The Bell V-280 Valor was selected as the Army's future long-range assault aircraft in 2022. Photo courtesy of Bell The US Army desi...
No comments:
Post a Comment